Xencor Inc
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1326732. Latest Form 4 filed Sep 8, 2021.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Inmune Bio, Inc.INMB | 10% owner | 5 | 2021-06-10 | 2021-09-03 |
Transactions: 5
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2021-09-03 | Inmune Bio, Inc.10% owner | Option exerciseStock Option (Right to Buy) | 108,000 | $0.00 | $0 | Form 4 |
| 2021-09-03 | Inmune Bio, Inc.10% owner | Option exercise | 108,000 | $7.80 | $842.4k | Form 4 |
| 2021-06-10 | Inmune Bio, Inc.10% owner | Other | 192,532 | $17.14 | $3.3m | Form 4 |
| 2021-06-10 | Inmune Bio, Inc.10% owner | Other | 192,533 | $17.14 | $3.3m | Form 4/A |
| 2021-06-10 | Inmune Bio, Inc.10% owner | Other | 192,533 | $17.14 | $3.3m | Form 4/A |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 07:20 ET. Listed shows no prices and gives no investment advice.